Riskpilot← Back to searchSign inGet full accessMedklippan AB
ABBankruptOrg 5564493194Engineering activities and related technical consultancy · NACE 7112Est. 19920 employees
Revenue 2023
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2023
—
0 employees
| Revenue | — | — |
| EBITDA | SEK 0 | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 0 | — |
Legal name
Medklippan AB
Org number
5564493194
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
31 juli 1992
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Aktiebolaget ska äga och förvalta värdepapper, idka konsultverksamhet med inriktning på management och organisation, ekonomisk redovisning och konsulterande ingenjörsverksamhet inom byggnadsområdet, elektricitet och maskinteknik samt idka annan därmed förenlig verksamhet.
Address
Email
linnea.jarnasen@lofalk.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 106 | 67 | 134 | 200 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | 46 | 35 | 85 | 61 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 46 | 35 | 85 | 61 | 0 |
| Net financials | −15 | −4 | −1 | −3 | — |
| Profit before tax | 32 | 32 | 84 | 58 | 0 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | 32 | 32 | 84 | 58 | — |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 100 | 100 | 194 | 266 | — |
| Equity | −196 | −164 | −80 | −22 | — |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 296 | 264 | 275 | 289 | — |
| Total debt | 296 | 264 | 275 | 289 | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20192023
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20192023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192023
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LS Liquidator | Liquidator | 2026 |
| Former (1) | ||
JA Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2020 – 2026 | |
| Deputy Board Member | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medklippan AB 
Clifftrade AktiebolagBoard members of Medklippan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linnea Sandelin-Järnåsen | Liquidator | 0 companies |
| Jaan Andres Kubja | Audit | 0 companies |
| Peter Sixtensson Frisk | Board of Directors | 0 companies |
| Göran Vilhelm Sixtensson Frisk | Deputy Board Member | 0 companies |